%0 Journal Article %A Rene Westhovens %A Lieven Annemans %T Costs of drugs for treatment of rheumatic diseases %D 2016 %R 10.1136/rmdopen-2016-000259 %J RMD Open %P e000259 %V 2 %N 2 %X The cost of drugs is becoming an issue worldwide, in particular for inflammatory rheumatic diseases. In the current review, an overview of the scene is given with a specific emphasis on accessibility for those patients in real need of the available expensive treatments. The authors propose 7 principles for discussion that need to be addressed and are a responsibility for all stakeholders in rheumatology. %U https://rmdopen.bmj.com/content/rmdopen/2/2/e000259.full.pdf